Anemia, characterized by a decrease in the number of red blood cells or less than the normal quantity of hemoglobin in the blood, is a common condition encountered in clinical practice. The diagnosis of anemia can be complex, given the wide range of potential etiologies. This article aims to provide a comprehensive diagnostic approach to anemia.
The initial evaluation of a patient suspected to have anemia should include a thorough history and physical examination. Key aspects of the patient's history include dietary habits, family history, and any symptoms suggestive of blood loss. Physical examination findings can provide clues to the underlying cause of anemia, such as pallor, jaundice, or splenomegaly.
Laboratory evaluation forms the cornerstone of anemia diagnosis. A complete blood count (CBC) and peripheral smear are the initial tests of choice. The CBC can provide information about the size of the red blood cells (mean corpuscular volume), which can help narrow down the differential diagnosis. The peripheral smear can provide additional clues, such as the presence of sickle cells or schistocytes.
Further diagnostic testing is guided by the results of the initial evaluation and laboratory tests. For example, a low serum ferritin level suggests iron deficiency anemia, while a positive fecal occult blood test may indicate gastrointestinal bleeding. In some cases, bone marrow biopsy may be necessary to confirm the diagnosis.
Given the myriad of potential causes, diagnosing anemia can be a complex process. A systematic approach that includes a thorough history and physical examination, initial laboratory evaluation, and guided further testing can help clinicians accurately diagnose and manage this common condition. Continued research and advancements in diagnostic tools will further aid in unraveling the complexities of anemia.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation